The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Crae, Scott Fraser
    Chief Medical Officer, Talking Medicines born in July 1969
    Individual (4 offsprings)
    Officer
    2013-04-10 ~ now
    OF - director → CIF 0
  • 2
    Halliday, Jo-anne
    Ceo, Talking Medicines born in January 1967
    Individual (6 offsprings)
    Officer
    2013-04-10 ~ now
    OF - director → CIF 0
  • 3
    Fairley, Elizabeth Anne Lyle, Dr
    Chief Operations Officer, Talking Medicines born in April 1975
    Individual (3 offsprings)
    Officer
    2016-08-18 ~ now
    OF - director → CIF 0
  • 4
    Sisto, Albert Ernest
    Ceo born in August 1949
    Individual (2 offsprings)
    Officer
    2020-11-04 ~ now
    OF - director → CIF 0
Ceased 6
  • 1
    Mr Scott Fraser Crae
    Born in July 1969
    Individual (4 offsprings)
    Person with significant control
    2016-04-06 ~ 2019-05-09
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 2
    Cons, Ben Major George
    Scientist born in March 1966
    Individual (1 offspring)
    Officer
    2019-05-09 ~ 2022-10-18
    OF - director → CIF 0
  • 3
    Mrs Jo-anne Halliday
    Born in January 1967
    Individual (6 offsprings)
    Person with significant control
    2016-04-06 ~ 2019-05-09
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 4
    Dr Elizabeth Anne Lyle Fairley
    Born in April 1975
    Individual (3 offsprings)
    Person with significant control
    2017-03-22 ~ 2017-06-28
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 5
    Younger, Simon Clovis
    Engineer born in September 1970
    Individual (6 offsprings)
    Officer
    2017-07-19 ~ 2020-11-24
    OF - director → CIF 0
  • 6
    Suite 2, Ground Floor, Orchard Brae House, 30 Queensferry Road, Edinburgh, United Kingdom
    Corporate (13 parents, 476 offsprings)
    Equity (Company account)
    2 GBP2024-03-31
    Officer
    2016-11-11 ~ 2023-07-20
    PE - secretary → CIF 0
parent relation
Company in focus

TALKING MEDICINES LIMITED

Previous names
VIRTUAL GENIE LIMITED - 2015-12-04
PURPLE PET PEOPLE LTD - 2013-11-07
Standard Industrial Classification
62012 - Business And Domestic Software Development
Brief company account
Property, Plant & Equipment
6,144 GBP2023-12-31
11,104 GBP2022-12-31
Fixed Assets - Investments
3 GBP2023-12-31
3 GBP2022-12-31
Debtors
Current
210,344 GBP2023-12-31
262,432 GBP2022-12-31
Cash at bank and in hand
36,756 GBP2023-12-31
336,465 GBP2022-12-31
Net Assets/Liabilities
-908,076 GBP2023-12-31
359,471 GBP2022-12-31
Equity
Called up share capital
380 GBP2023-12-31
380 GBP2022-12-31
Share premium
3,565,229 GBP2023-12-31
3,565,229 GBP2022-12-31
Retained earnings (accumulated losses)
-4,473,685 GBP2023-12-31
-3,209,682 GBP2022-12-31
Equity
-908,076 GBP2023-12-31
359,471 GBP2022-12-31
Property, Plant & Equipment - Depreciation rate used
Plant and equipment
152023-01-01 ~ 2023-12-31
Furniture and fittings
102023-01-01 ~ 2023-12-31
Average Number of Employees
292023-01-01 ~ 2023-12-31
342022-01-01 ~ 2022-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
738 GBP2023-12-31
738 GBP2022-12-31
Furniture and fittings
1,693 GBP2023-12-31
1,693 GBP2022-12-31
Computers
28,003 GBP2023-12-31
26,552 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
30,434 GBP2023-12-31
28,983 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
516 GBP2023-12-31
476 GBP2022-12-31
Furniture and fittings
961 GBP2023-12-31
816 GBP2022-12-31
Computers
22,813 GBP2023-12-31
16,587 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
24,290 GBP2023-12-31
17,879 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
40 GBP2023-01-01 ~ 2023-12-31
Furniture and fittings
145 GBP2023-01-01 ~ 2023-12-31
Computers
6,226 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
6,411 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment
Plant and equipment
222 GBP2023-12-31
262 GBP2022-12-31
Furniture and fittings
732 GBP2023-12-31
877 GBP2022-12-31
Computers
5,190 GBP2023-12-31
9,965 GBP2022-12-31
Investments in Subsidiaries
Cost valuation
3 GBP2023-12-31
3 GBP2022-12-31
Investments in Subsidiaries
3 GBP2023-12-31
3 GBP2022-12-31
Trade Debtors/Trade Receivables
Current
27,360 GBP2023-12-31
900 GBP2022-12-31
Amount of corporation tax that is recoverable
Current
100,000 GBP2023-12-31
208,928 GBP2022-12-31
Other Debtors
Current
17,318 GBP2023-12-31
48,605 GBP2022-12-31
Trade Creditors/Trade Payables
Current
172,204 GBP2023-12-31
38,571 GBP2022-12-31
Other Creditors
Current
199,159 GBP2023-12-31
187,245 GBP2022-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
206,813 shares2023-12-31
Par Value of Share
Class 1 ordinary share
0.001 GBP2023-01-01 ~ 2023-12-31
Nominal value of allotted share capital
Class 1 ordinary share
207 GBP2023-01-01 ~ 2023-12-31
207 GBP2022-01-01 ~ 2022-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
173,156 shares2023-12-31
Par Value of Share
Class 2 ordinary share
0.001 GBP2023-01-01 ~ 2023-12-31
Nominal value of allotted share capital
Class 2 ordinary share
173 GBP2023-01-01 ~ 2023-12-31
173 GBP2022-01-01 ~ 2022-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
2,170 GBP2023-12-31
18,501 GBP2022-12-31
Related profiles found in government register
  • TALKING MEDICINES LIMITED
    Info
    VIRTUAL GENIE LIMITED - 2015-12-04
    PURPLE PET PEOPLE LTD - 2013-11-07
    Registered number SC447227
    C/o Johnston Carmichael, 227 West George Street, Glasgow G2 2ND
    Private Limited Company incorporated on 2013-04-10 (12 years 2 months). The company status is Active.
    The last date of confirmation statement was made at 2024-09-04
    CIF 0
  • TALKING MEDICINES LIMITED
    S
    Registered number Sc447227
    C/o Talking Medicines Ltd, Beco Building, 58 Kingston Street, Glasgow, Scotland, G5 8BP
    Limited By Shares in United Kingdom, Scotland
    CIF 1 CIF 2
child relation
Offspring entities and appointments
Active 2
  • 1
    C/o Talking Medicines Ltd Beco Building, 58 Kingston Street, Glasgow, Scotland
    Corporate (4 parents)
    Equity (Company account)
    1 GBP2023-12-31
    Person with significant control
    2020-05-05 ~ now
    CIF 1 - Ownership of shares – 75% or more → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE
  • 2
    C/o Talking Medicines Ltd Beco Building, 58 Kingston Street, Glasgow, Scotland
    Corporate (4 parents)
    Equity (Company account)
    1 GBP2023-12-31
    Person with significant control
    2020-05-05 ~ now
    CIF 2 - Ownership of shares – 75% or more → OE
    CIF 2 - Ownership of voting rights - 75% or more → OE

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.